Assessment of the Relationship of REMS and MEWS Scores with Prognosis in Patients Diagnosed with COVID-19 Admitted to the Emergency Department

This article has been Reviewed by the following groups

Read the full article

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2021.01.24.21250384: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: Written informed consent was obtained from the patients for their anonymized information to be published in this article.
    IRB: The local Ethics Committee approved the study.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablePregnant patients, patients under 18, patients who did not consent to participate in the study, patients who had suffered trauma, pregnant women, and patients on drugs that are primarily effective on the central nervous system such as antidepressants, antipsychotics, etc. were not included in the study.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Limitation: The most important limitation of our study is that our number of patients and mortality rate are low. However, the study that has the largest number of patients in the literature happens to be our study. Our second limitation is that in our study, we did not separate the age groups of our patients based on decades. If we grouped patients based on their ages, we would probably find different mortality scores depending on the age group. Because in the REMS scoring system, different scores are received from different age groups. Another limitation is that we have not determined the mortality based on the treatment given to our patients. Keeping this factor in mind for other prospective studies on this subject will contribute to the literature.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.